논문명 Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.
발표지 Br J Clin Pharmacol 발표년월 2016.06
공동연구자 Hasunuma T, Tohkin M, Kaniwa N, Jang IJ, Yimin C, Kaneko M, Saito Y, Takeuchi M, Watanabe H,Yamazoe Y, Uyama Y, Kawai S
논문명 Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
발표지 Drug Des Devel Ther 발표년월 2016.04
공동연구자 Rhee SJ, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS.
논문명 The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
발표지 Drug Des Devel Ther 발표년월 2016.04
공동연구자 Gu N, Cho JY, Shin KH, Jang IJ, Rhee MY
논문명 Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
발표지 Seizure. 발표년월 2016.02
공동연구자 Bae EK, Lee J, Shin JW, Moon J, Lee KJ, Shin YW, Kim TJ, Shin D, Jang IJ, Lee SK
논문명 A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers
발표지 Int Clin Psychopharmacol 발표년월 2016.07
공동연구자 Kim A, Lim KS, Lee H, Chung H, Yoon SH, Yu KS, Cho JY, Jang IJ, Chung JY.
논문명 Inhibition of the MATE transporter by pyrimethamine increases the plasma concentration of metformin but does not increase anti-hyperglycaemic activity in humans.
발표지 Diabetes Obes Metab 발표년월 2016.01
공동연구자 Oh J, Chung H, Park SI, Yi S, Jang K, Kim A, Yoon J, Cho JY, Yoon SH, Jang IJ, Yu KS, Chung JY.
논문명 Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.
발표지 Cancer Res Treat 발표년월 2016.01
공동연구자 Oh DY, Kim TM, Han SW, Shin DY, Lee YG, Lee KW, Kim JH, Kim TY, Jang IJ, Lee JS, Bang YJ
논문명 The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
발표지 Epilepsia. 발표년월 2015.10
공동연구자 Moon J, Park HK, Chu K, Sunwoo JS, Byun JI, Lim JA, Kim TJ, Shin JW, Lee ST, Jung KH, Jung KY, Jeon D, Kim DW, Yu KS, Jang IJ, Kang HR, Park HW, Lee SK
논문명 Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form.
발표지 Sci Rep 발표년월 2015.10
공동연구자 Seo HJ, Nam SH, Im HJ, Park JY, Lee JY, Yoo B, Lee YS, Jeong JM, Hyeon T, Who Kim J, Lee JS, Jang IJ, Cho JY, Hwang do W, Suh YD, Lee DS
논문명 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
발표지 Epilepsy research 발표년월 2015.09
공동연구자 Jang HW, Kim SW, Cho YJ, Heo K, Lee BI, Lee SK, Jang IJ, Lee MG, Kim WJ, Lee JH.
논문명 Validated LC-MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies.
발표지 J Chromatogr Sci 발표년월 2015.09
공동연구자 Yoon SH, Oh S, Kim HS, Yi S, Yu KS, Jang IJ, Cho JY
논문명 Inhibition of the MATE transporter by pyrimethamine increases the plasma concentration of metformin but does not increase anti-hyperglycaemic activity in humans.
발표지 Diabetes Obes Metab 발표년월 2015.09
공동연구자 Oh J, Chung H, Park SI, Yi S, Jang K, Kim A, Yoon J, Cho JY, Yoon SH, Jang IJ, Yu KS, Chung JY.
논문명 Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.
발표지 Drug Des Devel Ther 발표년월 2015.08
공동연구자 Yoon S, Shin D, Lee H, Jang IJ, Yu KS.
논문명 Pharmacokinetics of Second-line Anti-Tuberculosis Drugs after Multiple Administrations in Healthy Volunteers.
발표지 Antimicrob Agents Chemother 발표년월 2015.08
공동연구자 Park SI, Oh J, Jang K, Yoon J, Moon SJ, Park JS, Lee JH, Song J, Jang IJ, Yu KS, Chung JY.
논문명 Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A.
발표지 Yonsei medical journal 발표년월 2015.07
공동연구자 Hyun SY, Park SY, Lee SY, Kook H, Paik SH, Jang IJ, Lee KS
논문명 Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation.
발표지 Clinical Drug Investigation 발표년월 2015.07
공동연구자 Kim H, Shin D, Kang HJ, Yu KS, Lee JW, Kim SJ, Kim MS, Song ES, Jang MK, Park JD, Jang IJ, Park KD, Shin HY, Ahn HS
논문명 A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.
발표지 Drug Des Devel Ther 발표년월 2015.05
공동연구자 Chung H, Lee H, Han H, An H, Lim KS, Lee Y, Cho JY, Yoon SH, Jang IJ, Yu KS.
논문명 Response to "Induction of both P-glycoprotein and specific cytochrome P450 by aspirin eventually does not alter the antithrombotic effect of clopidogrel"
발표지 Clin Pharmacol Ther 발표년월 2015.04
공동연구자 Oh J, Ji SC, Lee H, Yu KS, Jang IJ
논문명 Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy korean volunteers.
발표지 Clin Ther 발표년월 2015.04
공동연구자 Kim BH, Yu KS, Jang IJ, Soo Lim K, Kim JR, Elshoff JP, Andreas JO, Braun M, Cawello W
논문명 Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.
발표지 Cancer Res Treat 발표년월 2015.02
공동연구자 Oh DY, Kim TM, Han SW, Shin DY, Lee YG, Lee KW, Kim JH, Kim TY, Jang IJ, Lee JS, Bang YJ